Hyperhomocysteinemia Clinical Trial
Official title:
Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms: A Randomized, Double-blind, Placebo-controlled Trial
This randomized, double-blind, placebo-controlled trial will evaluate the impact of methylfolate, pyridoxal-5'-phosphate (P5P), and methylcobalamin supplementation on homocysteine and LDL-C levels in individuals with low to medium cardiac risk and MTHFR, MTR, and MTRR gene polymorphisms. The study aims to explore the efficacy of these vitamins in reducing homocysteine levels, a critical risk factor for cardiovascular disease (CVD), while also monitoring LDL-C levels. The findings will offer valuable insights into personalized CVD prevention and management, emphasizing the significance of genetic factors in nutritional therapy.
Design: Participants with specific genetic polymorphisms and homocysteine levels above 15 µmol/L, without a history of severe CVD or other exclusion criteria, will be enrolled and randomized into two groups: one receiving methylfolate, P5P, and methylcobalamin, and the other a placebo. The study, adhering to ethical standards and informed consent, will involve 54 patients divided equally between the treatment and placebo groups. The primary endpoint will be the percent change in homocysteine levels over six months, with secondary endpoints including changes in LDL-C and other lipid profile components. Intervention: Participants will receive either the active treatment (L-methylfolate, P5P, and Methylcobalamin) or a placebo, with both groups taking two capsules daily for 180 days. Fasting measurements of lipid profiles and homocysteine levels will be conducted at the start, midpoint, and end of the study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00005482 -
Homocyst(e)Ine, Vitamin Status, and CVD Risk
|
N/A | |
| Recruiting |
NCT06264570 -
Evaluation of a Genetically Determined Personalized Approach in Prescribing Biologically Active Substances in Patients With Elevated Blood Homocysteine Levels.
|
N/A | |
| Completed |
NCT02392767 -
Effect of L-Arginine and Pycnogenol on Light to Moderate Hypertension and Endothelial Function
|
N/A | |
| Completed |
NCT02540642 -
Effect of Vitamin B12 Supplementation on Glycaemic Control in Uncontrolled Hyperhomocysteinemic Type 2 Diabetic Patients
|
N/A | |
| Completed |
NCT01371357 -
The Effects of 8-week Choline, Betaine, and Folic Acid Supplementation on Plasma Homocysteine Concentration During Guanidinoacetic Acid Loading in Young Healthy Volunteers
|
Phase 3 | |
| Withdrawn |
NCT01871740 -
CSPPT- Chronic Kidney Diseases Study
|
Phase 4 | |
| Not yet recruiting |
NCT03720249 -
Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults With Hyperhomocysteinemia
|
N/A | |
| Completed |
NCT01391416 -
Prevalence Of Hyperhomocysteinemia In Thai Chronic Kidney Disease (CKD) Patients
|
N/A | |
| Completed |
NCT00004495 -
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
|
N/A | |
| Completed |
NCT00755664 -
Effects of Low-dose Complex B-vitamins on Homocysteine and Framingham Risk Score Among Chinese Elderly
|
Phase 3 | |
| Completed |
NCT02961972 -
Effects of Oral Supplementation With Creatine on Systemic Microvascular Endothelial Function in Vegetarian Individuals
|
N/A | |
| Completed |
NCT02860338 -
COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
|
N/A | |
| Completed |
NCT00737126 -
The Effect of Folic Acid Administration in the Progression of Microalbuminuria
|
N/A | |
| Completed |
NCT00626223 -
5-methyltetrahydrofolate Survival and Inflammation in ESRD Patients
|
N/A | |
| Completed |
NCT03631238 -
The Dual Impact of Homocysteine and Cholesterol on Cognitive Functions
|
||
| Completed |
NCT03376490 -
Study of the Association of Muscle Strength, Balance and Other Factors With Vitamin Levels Among Elderly Diabetics
|
N/A | |
| Enrolling by invitation |
NCT02817503 -
Feasibility Study of the Intensive Systolic Blood Pressure Control
|
Phase 4 | |
| Completed |
NCT01766310 -
Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children
|
Phase 4 | |
| Completed |
NCT00005483 -
Plasma Homocysteine Distribution in the United States
|
N/A | |
| Completed |
NCT00473200 -
Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine
|
Phase 1 |